{"protocolSection": {"identificationModule": {"nctId": "NCT03106870", "orgStudyIdInfo": {"id": "Metformin"}, "organization": {"fullName": "Ain Shams University", "class": "OTHER"}, "briefTitle": "Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus", "officialTitle": "Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus and Improving Neonatal Outcome Regarding Birth Weight"}, "statusModule": {"statusVerifiedDate": "2017-05", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2016-06", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2016-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2016-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-03-28", "studyFirstSubmitQcDate": "2017-04-04", "studyFirstPostDateStruct": {"date": "2017-04-11", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2017-04-14", "resultsFirstSubmitQcDate": "2017-05-19", "resultsFirstPostDateStruct": {"date": "2017-06-14", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2017-05-19", "lastUpdatePostDateStruct": {"date": "2017-06-14", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Rehab Mohamed Abdelrahman", "investigatorTitle": "Lecturer of Obstetrics and Gynaecology Faculty of Medicine, Ain Shams University", "investigatorAffiliation": "Ain Shams University"}, "leadSponsor": {"name": "Ain Shams University", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The purpose of the study to prove benefits of adding metformin to insulin for controlling presentational and gestational diabetes mellitus and improving neonatal outcome.", "detailedDescription": "The current study was conducted at Ain Shams university maternity hospital during the period between June 2016 to December 2016.\n\nAll patients were subjected to:\n\n1. History taking:\n2. General and Abdominal Examination:\n\n   With particular emphasis on :\n   * Body mass index\n   * Blood pressure.\n   * Fundal height .\n   * Estimated fetal weight .\n3. Insulin and metformin doses :\n\n   Insulin dose:\n\n   0.7 IU/Kg (at the second trimester of pregnancy). 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.\n\n   Metformin dose :\n\n   Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.\n\n   If the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day.\n4. Investigations:\n\nFasting and two hours postprandial blood glucose levels were measured in two groups of pregnant women:\n\n1. Group I: pregnant women who received oral metformin in addition to insulin therapy.\n2. Group II: pregnant women who received insulin therapy only."}, "conditionsModule": {"conditions": ["Gestational Diabetes Mellitus in Pregnancy"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "interventionModelDescription": "Group I: pregnant women who received oral metformin in addition to insulin therapy.\n\nGroup II: pregnant women who received insulin therapy only.", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "SINGLE", "maskingDescription": "Sixty-two opaque envelopes were numbered serially and in each envelope the corresponding letter which detect allocated group were put according to randomization then all envelops were closed and put in one box .When the first patient arrives , the first envelope were opened and the patient were allocated according to the letter inside .", "whoMasked": ["PARTICIPANT"]}}, "enrollmentInfo": {"count": 62, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "oral metformin and insulin", "type": "ACTIVE_COMPARATOR", "description": "Intervention 'Insulin Mixtard' and Intervention 'metformin' had included", "interventionNames": ["Drug: Insulin Mixtard", "Drug: Metformin"]}, {"label": "insulin therapy only", "type": "ACTIVE_COMPARATOR", "description": "Intervention 'Insulin Mixtard' had included", "interventionNames": ["Drug: Insulin Mixtard"]}], "interventions": [{"type": "DRUG", "name": "Insulin Mixtard", "description": "Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.", "armGroupLabels": ["insulin therapy only", "oral metformin and insulin"], "otherNames": ["insulin mixtures"]}, {"type": "DRUG", "name": "Metformin", "description": "Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.\n\nIf the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day.", "armGroupLabels": ["oral metformin and insulin"], "otherNames": ["Metformin Hydrocloride"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants With Glycemic Control Over Period From 20 Weeks to 36 Weeks Gestation", "description": "Fasting and two-hours postprandial blood glucose every 48 hours, till reaching the target blood glucose concentrations:\n\n60 - 95 mg/dl and \\< 120 mg/dl (for fasting and two-hour postprandial status, respectively) If patient reached blood glucose concentrations, she considered as controlled Diabetes Mellitus If patient did not reach blood glucose concentrations, she considered as uncontrolled Diabetes Mellitus", "timeFrame": "from 20 weeks to 36 weeks gestation"}], "secondaryOutcomes": [{"measure": "Number of Participants With a Macrosomic Baby", "description": "Fetal macrosomia has been defined birth weight greater than 4500 gm", "timeFrame": "24 hours after delivery"}, {"measure": "Number of Participants With Neonates Who Were Hypoglycemic", "description": "Neonatal hypoglycemia defined as a plasma glucose level of less than 30 mg/dL in the first 24 hours after delivery", "timeFrame": "24 hours after delivery"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Age 20 - 35 years.\n2. Gestational age: 20- 36 weeks gestation.\n3. Singleton pregnancy.\n4. Women with pregestational or gestational diabetes mellitus\n\nExclusion Criteria:\n\n1. Pregnant women with secondary diabetes (e.g. those on chronic steroid therapy).\n2. Hypertensive patients.\n3. Women with impaired liver or renal function\n4. Non-compliant patients.", "healthyVolunteers": true, "sex": "FEMALE", "minimumAge": "20 Years", "maximumAge": "35 Years", "stdAges": ["ADULT"]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "The current study was conducted at Ain Shams university maternity hospital during the period between June 2016 to December 2016.\n\nSixty two pregnant women were recruited from Ain Shams university maternity hospital who fulfilled the inclusion criteria. They were counseled and after consenting were included into the study.", "groups": [{"id": "FG000", "title": "Oral Metformin and Insulin", "description": "Intervention 'Insulin Mixtard' and Intervention 'metformin' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.\n\nMetformin: Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.\n\nIf the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day."}, {"id": "FG001", "title": "Insulin Therapy Only", "description": "Intervention 'Insulin Mixtard' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "31"}, {"groupId": "FG001", "numSubjects": "31"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "31"}, {"groupId": "FG001", "numSubjects": "31"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Oral Metformin and Insulin", "description": "Intervention 'Insulin Mixtard' and Intervention 'metformin' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.\n\nMetformin: Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.\n\nIf the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day."}, {"id": "BG001", "title": "Insulin Therapy Only", "description": "Intervention 'Insulin Mixtard' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "62"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "62"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "28.9", "spread": "3.9"}, {"groupId": "BG001", "value": "29.7", "spread": "3.5"}, {"groupId": "BG002", "value": "29.3", "spread": "3.7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "62"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Egypt", "categories": [{"measurements": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "62"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants With Glycemic Control Over Period From 20 Weeks to 36 Weeks Gestation", "description": "Fasting and two-hours postprandial blood glucose every 48 hours, till reaching the target blood glucose concentrations:\n\n60 - 95 mg/dl and \\< 120 mg/dl (for fasting and two-hour postprandial status, respectively) If patient reached blood glucose concentrations, she considered as controlled Diabetes Mellitus If patient did not reach blood glucose concentrations, she considered as uncontrolled Diabetes Mellitus", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "from 20 weeks to 36 weeks gestation", "groups": [{"id": "OG000", "title": "Oral Metformin and Insulin", "description": "Intervention 'Insulin Mixtard' and Intervention 'metformin' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.\n\nMetformin: Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.\n\nIf the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day."}, {"id": "OG001", "title": "Insulin Therapy Only", "description": "Intervention 'Insulin Mixtard' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "31"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "24"}, {"groupId": "OG001", "value": "27"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With a Macrosomic Baby", "description": "Fetal macrosomia has been defined birth weight greater than 4500 gm", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 hours after delivery", "groups": [{"id": "OG000", "title": "Oral Metformin and Insulin", "description": "Intervention 'Insulin Mixtard' and Intervention 'metformin' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.\n\nMetformin: Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.\n\nIf the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day."}, {"id": "OG001", "title": "Insulin Therapy Only", "description": "Intervention 'Insulin Mixtard' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "31"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "12"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Neonates Who Were Hypoglycemic", "description": "Neonatal hypoglycemia defined as a plasma glucose level of less than 30 mg/dL in the first 24 hours after delivery", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 hours after delivery", "groups": [{"id": "OG000", "title": "Oral Metformin and Insulin", "description": "Intervention 'Insulin Mixtard' and Intervention 'metformin' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.\n\nMetformin: Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.\n\nIf the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day."}, {"id": "OG001", "title": "Insulin Therapy Only", "description": "Intervention 'Insulin Mixtard' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "31"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "6"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "7 months from June 2016 to December 2016", "description": "Adverse Events of oral metformin and insulin were assessed.", "eventGroups": [{"id": "EG000", "title": "Oral Metformin and Insulin", "description": "Intervention 'Insulin Mixtard' and Intervention 'metformin' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.\n\nMetformin: Oral metformin at a dose of 1500 mg divided into three doses, were taken with meals, in addition to insulin.\n\nIf the target blood glucose concentrations were not attained, the dose of metformin was raised to 2000 mg per day.", "seriousNumAffected": 0, "seriousNumAtRisk": 31, "otherNumAffected": 0, "otherNumAtRisk": 31}, {"id": "EG001", "title": "Insulin Therapy Only", "description": "Intervention 'Insulin Mixtard' had included\n\nInsulin Mixtard: Insulin dose:\n\n* 0.7 IU/Kg (at the second trimester of pregnancy).\n* 0.8 IU/Kg (at the third trimester of pregnancy). Insulin dose was raised at a rate of 1 IU for every 10 mg/dl higher than the target blood glucose concentration.", "seriousNumAffected": 0, "seriousNumAtRisk": 31, "otherNumAffected": 0, "otherNumAtRisk": 31}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr.Rehab Mohamed Abdelrahman", "organization": "Ain Shams University", "email": "rehababdulrahman.rm@gmail.com", "phone": "+201004992772"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000016640", "term": "Diabetes, Gestational"}, {"id": "D000011254", "term": "Pregnancy in Diabetics"}, {"id": "D000003920", "term": "Diabetes Mellitus"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}, {"id": "D000011248", "term": "Pregnancy Complications"}, {"id": "D000005261", "term": "Female Urogenital Diseases and Pregnancy Complications"}, {"id": "D000091642", "term": "Urogenital Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M5114", "name": "Body Weight", "relevance": "LOW"}, {"id": "M19012", "name": "Diabetes, Gestational", "asFound": "Gestational Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M14133", "name": "Pregnancy in Diabetics", "asFound": "Diabetes Mellitus in Pregnancy", "relevance": "HIGH"}, {"id": "M5006", "name": "Birth Weight", "relevance": "LOW"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}, {"id": "M14127", "name": "Pregnancy Complications", "relevance": "LOW"}, {"id": "M2875", "name": "Urogenital Diseases", "relevance": "LOW"}, {"id": "M27093", "name": "Female Urogenital Diseases", "relevance": "LOW"}, {"id": "M8399", "name": "Female Urogenital Diseases and Pregnancy Complications", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "BXS", "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000007328", "term": "Insulin"}, {"id": "C000557859", "term": "Insulin, Globin Zinc"}, {"id": "D000008687", "term": "Metformin"}, {"id": "C000557578", "term": "Insulin, pork; isophane insulin, pork drug combination 30:70"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M10365", "name": "Insulin", "asFound": "Blood", "relevance": "HIGH"}, {"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M173166", "name": "Insulin, Globin Zinc", "asFound": "Blood", "relevance": "HIGH"}, {"id": "M29799", "name": "Biphasic Insulins", "relevance": "LOW"}, {"id": "M17768", "name": "Zinc", "relevance": "LOW"}, {"id": "M327", "name": "Isophane Insulin, Human", "relevance": "LOW"}, {"id": "M10373", "name": "Insulin, Isophane", "relevance": "LOW"}, {"id": "M173174", "name": "Isophane insulin, beef", "relevance": "LOW"}, {"id": "M227157", "name": "Insulin, pork; isophane insulin, pork drug combination 30:70", "asFound": "Cemiplimab-rwlc", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Micro", "name": "Micronutrients"}]}}, "hasResults": true}